Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype.
about
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.Regulation of nausea and vomiting by cannabinoids and the endocannabinoid systemVagus nerve stimulation reduces body weight and fat mass in ratsCannabinoids, eating behaviour, and energy homeostasis.Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats.Putative roles of neuropeptides in vagal afferent signaling.Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.Role of corticosterone in the murine enteric nervous system during fasting.Gastrointestinal hormones and the dialogue between gut and brain.Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity.Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity.The role of the gut-brain axis in alcohol use disorders.Peripheral neural targets in obesityPharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.A potential role for GPR55 in gastrointestinal functionsMedullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression.Deficits in gastrointestinal responses controlling food intake and body weight.Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance.The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.Role of the vagus nerve in the development and treatment of diet-induced obesity.Nutritional status-dependent endocannabinoid signalling regulates the integration of rat visceral information.High fat diet and body weight have different effects on cannabinoid CB(1) receptor expression in rat nodose ganglia.Pro-inflammatory obesity in aged cannabinoid-2 receptor-deficient mice.Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Visceral Inflammation and Immune Activation Stress the Brain.Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea.Localization of mGluR5, GABAB, GABAA, and cannabinoid receptors on the vago-vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study.Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse.
P2860
Q21132308-8C9203AA-A024-43EF-833D-1D09595A6A64Q28301264-81F5B113-BCA2-45B0-A32A-E1C432D334EDQ28484122-85D25051-0C42-4758-8010-3C31541FF038Q30357350-D022245C-495F-406F-8140-6278DFBFCA77Q34193583-36069413-6822-4B9A-B9DE-43DE925341A5Q34207352-5DA5EA2F-93FA-4274-A8F1-03F853E0D589Q34415497-59EAD55E-8066-4067-85DB-9A7A81C903DAQ34439828-42EA9CAB-5F35-4792-97EB-18763A840337Q35102422-22E1F910-0FF9-410B-BFC0-64D94690E775Q35582616-288FDF5F-2793-4596-BD61-68A3CB871320Q35642904-4859945A-9C6D-43DD-989E-50C488CDD6CAQ35696171-74B26E2A-FF2A-42D1-8B21-941C5F9D34FEQ36166645-14098466-9E09-4626-B377-2120A6FC45C9Q36797357-FD478654-B72C-4A72-883A-3B887BE9EC12Q36801981-180AF9FE-59F3-4D1B-8250-1FE4D1C3D693Q36864469-BE1A5EB8-6961-470F-8103-9C8F03DB23A4Q36985211-1A5D9017-44CB-4D62-8028-969FD4F54650Q37791290-6B2F2EDA-C440-432A-9D39-68423D55F946Q37808286-87B14BFB-3558-40C5-8ABD-3E9C54416E32Q37913717-12CCD5E0-0AD5-4690-B0E6-B4C80C9965EAQ38766761-A982FB6B-870D-4797-8415-DA45CCDFD0C6Q38944697-2FBB9D90-FE53-4C0E-95E3-241C7B0C9E0DQ42091620-58C3FCBE-4C57-419A-8CBE-A3F2C9F37847Q42823729-2BE9D63F-D50F-428C-8FC1-5383EF2D33CEQ45288843-2AAED6EA-0B37-4790-93AF-C1429CD7C0FDQ47137050-4BD4CAA5-0334-4B8E-BB3E-AAE008D510D4Q47664424-ACA1FB67-9989-470D-A89F-FD0C13CFDDF3Q48704972-5D7641C8-8811-4EE2-88C0-FDF2ABFCFB6DQ50278777-682B8CC8-73F0-4E57-8F86-43A85B53A3E7
P2860
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expression of cannabinoid CB1 ...... ncing neurochemical phenotype.
@ast
Expression of cannabinoid CB1 ...... ncing neurochemical phenotype.
@en
type
label
Expression of cannabinoid CB1 ...... ncing neurochemical phenotype.
@ast
Expression of cannabinoid CB1 ...... ncing neurochemical phenotype.
@en
prefLabel
Expression of cannabinoid CB1 ...... ncing neurochemical phenotype.
@ast
Expression of cannabinoid CB1 ...... ncing neurochemical phenotype.
@en
P2093
P2860
P921
P356
P1476
Expression of cannabinoid CB1 ...... ncing neurochemical phenotype.
@en
P2093
Andrea Varro
David G Thompson
Galina Burdyga
Graham J Dockray
Rod Dimaline
P2860
P356
10.1152/AJPGI.00059.2010
P577
2010-04-29T00:00:00Z